In sum, this research provided basic data supporting the potential of turmeric and its active components, especially curcumin, demethoxycurcumin, and bisdemethoxycurcumin, as pancreatic lipase inhibitors, a finding which might contribute to their application in anti-obesity products, such as functional foods or pharmaceuticals. The gene discussed is PNLIP; the disease is obesity disorder.